European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 3.900
-0.140 (-3.47%)
Sep 18, 2026, 3:58 PM CET
EBR:ALEMS Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 17 | 22 | 25 | 35 | 83 | 5 | |
Market Cap Growth | -16.12% | -13.33% | -27.47% | -57.73% | 1588.91% | 0.90% |
Enterprise Value | 33 | 38 | 41 | 49 | 94 | 8 |
Last Close Price | 3.90 | 5.20 | 6.00 | 8.27 | 19.57 | 78.85 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.02 | 11.96 | 46.50 | - | - | - |
PS Ratio | 0.32 | 0.42 | 0.53 | 0.82 | 2.24 | 0.13 |
PB Ratio | 1.26 | 1.83 | 2.46 | 3.54 | 7.78 | 0.45 |
P/TBV Ratio | 1.32 | 1.91 | 2.60 | 3.81 | 8.06 | 0.47 |
P/FCF Ratio | 14.05 | 8.82 | - | - | - | - |
P/OCF Ratio | 4.18 | 4.09 | 9.94 | - | 39.57 | 14.09 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.64 | 0.73 | 0.86 | 1.16 | 2.55 | 0.20 |
EV/EBITDA Ratio | 10.46 | 13.10 | 12.51 | 23.88 | 40.64 | 3.68 |
EV/EBIT Ratio | 11.41 | 15.37 | 32.88 | - | - | 63.96 |
EV/FCF Ratio | 27.81 | 15.41 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.46 | 1.55 | 1.92 | 1.90 | 1.39 | 1.24 |
Debt / EBITDA Ratio | 6.16 | 5.23 | 6.02 | 9.11 | 6.37 | 6.58 |
Debt / FCF Ratio | 16.39 | 7.49 | - | - | - | - |
Net Debt / Equity Ratio | 1.23 | 1.14 | 1.48 | 1.47 | 0.99 | 1.02 |
Net Debt / EBITDA Ratio | 6.43 | 4.70 | 4.63 | 7.08 | 4.55 | 5.40 |
Net Debt / FCF Ratio | 13.77 | 5.53 | -15.03 | -3.01 | -90.21 | -7.04 |
Asset Turnover | 1.00 | 1.05 | 1.04 | 1.02 | 0.97 | 1.84 |
Inventory Turnover | 2.42 | 2.48 | 2.23 | 2.00 | 1.89 | - |
Quick Ratio | 0.94 | 0.71 | 0.61 | 0.60 | 0.63 | 0.67 |
Current Ratio | 1.70 | 1.41 | 1.53 | 1.60 | 1.51 | 1.56 |
Return on Equity (ROE) | 16.91% | 16.43% | 5.40% | -6.93% | -51.86% | -9.17% |
Return on Assets (ROA) | 3.48% | 3.12% | 1.70% | -0.20% | -2.91% | 0.36% |
Return on Invested Capital (ROIC) | 9.17% | 9.39% | 3.64% | -0.59% | -8.22% | 1.41% |
Return on Capital Employed (ROCE) | 9.50% | 9.70% | 4.80% | -0.60% | -8.20% | 0.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 11.72% | 8.36% | 2.15% | -2.02% | -6.73% | -4.91% |
FCF Yield | 7.12% | 11.33% | -4.00% | -13.84% | -0.14% | -32.08% |
Buyback Yield / Dilution | - | - | 0.00% | - | -6081.03% | -10.08% |